Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial - Test2 - elhamkhani - TriplyDB

Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial

Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial

http://www.wikidata.org/entity/Q24628047

about

Supplementary oxygen for nonhypoxemic patients: O2 much of a good thing?Integrated Palliative Care and Oncologic Care in Non-Small-Cell Lung Cancer Dyspnea review for the palliative care professional: treatment goals and therapeutic options Palliative Care of Adult Patients With Cancer Symptom management in the older adult: 2015 update Developing a Research Agenda for Integrating Palliative Care into Critical Care and Pulmonary Practice To Improve Patient and Family Outcomes.Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial.Palliative care in the ICU: relief of pain, dyspnea, and thirst--a report from the IPAL-ICU Advisory Board.An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.Building the palliative care evidence base: Lessons from a randomized controlled trial of oxygen vs room air for refractory dyspnea.An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis.[Pharmacological therapy of refractory dyspnoea : a systematic literature review].Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy.Oxygen therapy for COPD.Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: a feasibility pilot.Long-Term Oxygen Therapy 24 vs 15 h/day and Mortality in Chronic Obstructive Pulmonary Disease Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: 'Swimming between the flags'.Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review.Pulmonary Rehabilitation and Palliative Care for the Lung Cancer Patient.A possible role for systemic hypoxia in the reactive component of pulmonary hypertension in heart failure.Exercise therapy in the management of dyspnea in patients with cancer.The potential harm of oxygen therapy in medical emergencies.The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea Shortness of breath and cough in patients in palliative care.Practical Dyspnea Assessment: Relationship Between the 0-10 Numerical Rating Scale and the Four-Level Categorical Verbal Descriptor Scale of Dyspnea Intensity.High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial.Overcoming recruitment challenges in palliative care clinical trials Heart rate variability during treatment of breakthrough pain in patients with advanced cancer: a pilot study.Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people w Achieving palliative care research efficiency through defining and benchmarking performance metrics.Pain Management and Symptom-Oriented Drug Therapy in Palliative Care.Palliative care concepts in respiratory disease.Breathlessness--current and emerging mechanisms, measurement and management: a discussion from an European Association of Palliative Care workshop.Oxygen for end-of-life lung cancer care: managing dyspnea and hypoxemia.An official American Thoracic Society workshop report: assessment and palliative management of dyspnea crisis.Outcome measures for palliative oxygen therapy: relevance and practical utility.Oxygen therapy: time to move on?How do respiratory patients perceive oxygen therapy? A critical interpretative synthesis of the literature.

P2860

Q24625685-F62721F0-5F1D-418A-A1E8-A1048FF3EDD1 Q26749199-4ECD39D2-901C-4984-8F15-1EB512765325 Q26822728-857F1DEB-CD21-4DDB-8B82-9CE63504DA1E Q28079107-571F7393-B0D4-4940-9FF2-2E4FA555EBB2 Q30374202-73972F39-4347-4305-957B-75702F707076 Q30400759-DAA42345-21F8-4A02-915A-F6958DB5AF57 Q30401937-913735A1-3024-4500-A023-8CFDF3387264 Q31094114-0DED9931-5E0E-4511-A7A5-2D19BB414A6E Q33672292-C923DC9C-2BB1-46F4-ACC3-AB8C4C830310 Q33738878-FD93DC26-B402-4D65-992E-3A7190AA5B11 Q34152566-B0A776AA-FBC6-4562-A83B-353C4BD8C461 Q34251877-36DF93D1-61EA-4E45-BBAC-ECD7C9A2BE22 Q34397960-19A0A684-5A77-4FBF-A9EB-9BA183DC601F Q34407546-6896F6D0-B2A0-45F9-80CB-990545A8751C Q34545876-8C605512-E660-47F2-AE8D-C9F2D2A249DA Q34628625-DE95EE96-4E89-4B8F-9408-BFB87B948B90 Q36070774-B72E88E3-65FA-4EAF-80B3-969064112FF0 Q36138494-0B1A6A06-1251-4B21-B3DC-DE429A0F85D9 Q36302721-F02065CD-6F87-4AB8-9CFD-B58E2B2B6BD2 Q36378102-7D513BC8-52C3-42C0-860C-85ED11CA0073 Q36402410-9C665158-8529-4B0A-BD9F-EA840D1D5182 Q36521897-6B2DED57-318A-4A44-91FD-2DC7C74A870A Q36747257-23DB2B38-08AF-4050-AF7E-33603ED0597C Q36902502-BC2A73E9-E421-4C24-A80A-401417548183 Q37032302-CAD71730-F954-475F-BC2F-C90E0109BFFB Q37194917-856862E9-169D-4C9E-AF8B-1B4BDD47DE07 Q37227092-1B8F2E14-19EE-428F-BC03-FF19DF2876F4 Q37228008-768D602B-3592-4FF6-AF3F-47689C8DA8D8 Q37301403-931BCC07-2B16-4A85-AE83-B2C466409C93 Q37509966-27585703-5B1D-48F2-8307-57CD730F4F57 Q37516685-249E87F7-3FB0-4A64-BCBB-4A910166A395 Q37597308-94DAFEE4-7BF7-449F-A288-6BBCAD0280FC Q37872595-C82EA504-8DF8-439E-A2DC-A7CA357644BD Q37960814-2F030F04-8EF5-4717-9E78-DB06009F442E Q38120357-7F5611A2-BA65-43E1-8677-AEF4CFE57AE8 Q38153817-489E62F8-0771-49A9-8E3C-445AAF8FDA82 Q38155655-5AD54B44-08B8-4CD2-81C2-51EFE223CB62 Q38205254-0B1E8159-1E6D-4DB6-86B5-372C22D0900C Q38247478-1DDC5E95-5AA7-4E99-ACA5-8246ECDAA888 Q38253999-7104E5F4-6351-45DC-BC05-D21E6AB29714

P2860

Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial

http://www.wikidata.org/entity/Q24628047

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Effect of palliative oxygen ve ...... d, randomised controlled trial

@ast

Effect of palliative oxygen ve ...... d, randomised controlled trial

@en

Effect of palliative oxygen ve ...... d, randomised controlled trial

@nl

type

label

Effect of palliative oxygen ve ...... d, randomised controlled trial

@ast

Effect of palliative oxygen ve ...... d, randomised controlled trial

@en

Effect of palliative oxygen ve ...... d, randomised controlled trial

@nl

prefLabel

Effect of palliative oxygen ve ...... d, randomised controlled trial

@ast

Effect of palliative oxygen ve ...... d, randomised controlled trial

@en

Effect of palliative oxygen ve ...... d, randomised controlled trial

@nl

P1433

Q24628047-18623719-63BB-452D-958E-D02AC740DD17

P1476

Q24628047-425A781C-83F4-4602-B499-3F7DFB9E789C

P2093

Q24628047-1CB30264-F7D7-4516-BC4A-FA42D530FE57

Q24628047-3DFA991C-37CA-4B45-A2E5-63BA6D6C0FBD

Q24628047-49545B7E-0AA5-4C38-B936-3BB80E0DD581

Q24628047-7971DA79-EE5B-4BE2-8592-F7F868B8FEE2

Q24628047-87942E7C-36C2-4713-B969-65779E8D9B52

Q24628047-A3EF8B60-9534-485D-BA51-57677BDFBC94

Q24628047-C7A9155A-2F90-4820-8033-D5E8C7DA4297

Q24628047-E64E7259-B5FC-44EE-9A22-02C0545E4EAE

Q24628047-FAC62CDC-EAEF-4417-B856-A440D39C0741

P2860

Q24628047-0CED0259-2B3E-4BCC-A6C2-CEF0E4738C38

Q24628047-0F839BD3-8A23-4F19-B3AA-16BF82314F4C

Q24628047-14D93034-9959-4795-B908-F38132F37999

Q24628047-16E9CDD1-1BD8-4D38-B6D5-11326368CCBF

Q24628047-1909553D-16FB-408E-A547-EADBBF03C375

Q24628047-267B446F-540E-4CD4-8552-B78AF7565C86

Q24628047-43480098-0988-4D32-B17F-FB3ED73F1526

Q24628047-43CF1EFF-2A44-43EA-9E2B-74CDC8F20820

Q24628047-44FDE320-0E52-48FD-AD15-8152FEF23977

Q24628047-7477E9E8-5F11-4CF6-AC01-02036E3F564D

P304

Q24628047-D9EC60FA-33A4-43D7-AB22-7039FDB7F2EC

P31

Q24628047-31FA2EE1-B24B-4B9A-8600-DFA15A0435EB

P3181

Q24628047-553B3661-3A8D-4104-AA10-2836214B6FAC

P356

Q24628047-A2A60530-CDD0-4670-9FA7-B79B816204B1

P407

Q24628047-97171EC3-D7FA-45A5-80BD-065E93281276

P433

Q24628047-A90F0DAA-C2FA-4F93-9C58-B73C14246188

P478

Q24628047-C065BF1B-F4AE-460C-9513-261322934F48

P50

Q24628047-05BCE6B5-2538-44FD-A0DD-16F53B9074A5

Q24628047-147FA969-BCEE-4A15-B62A-F37D40D73488

Q24628047-412C8480-002B-4EE8-84F1-F86C7A80A886

Q24628047-536AB8A8-CC75-473C-B5DF-28564FBC1235

Q24628047-D191C63B-555D-4138-9CE9-3680C7A5E930

P577

Q24628047-EC046CFB-F31D-41B7-A2F3-32A7F76ACC31

P698

Q24628047-CBE29007-4ECC-4F7F-B7CD-0DCBAE221F49

P932

Q24628047-49ABE205-D160-432E-B946-0530BCA8954D

P3181

P356

S0140-6736(10)61115-4

P1433

P1476

Effect of palliative oxygen ve ...... d, randomised controlled trial

@en

P2093

Alan J Crockett

http://www.w3.org/2001/XMLSchema#string

Christine F McDonald

http://www.w3.org/2001/XMLSchema#string

Iven H Young

http://www.w3.org/2001/XMLSchema#string

James A Tulsky

http://www.w3.org/2001/XMLSchema#string

James E Herndon

http://www.w3.org/2001/XMLSchema#string

Jane L Wheeler

http://www.w3.org/2001/XMLSchema#string

Janet Bull

http://www.w3.org/2001/XMLSchema#string

Jennifer Marcello

http://www.w3.org/2001/XMLSchema#string

Katherine Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease

Oxygen therapy for dyspnoea in adults

Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases

“Mini-mental state”

Toxicity and response criteria of the Eastern Cooperative Oncology Group

A systematic review of the use of opioids in the management of dyspnoea.

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Home oxygen therapy: adjunct or risk factor?

The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine.

Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea

P304

784-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1959097

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0140-6736(10)61115-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

9743

http://www.w3.org/2001/XMLSchema#string

P478

376

http://www.w3.org/2001/XMLSchema#string

P50

David C. Currow

Amy P. Abernethy

P577

2010-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20816546

http://www.w3.org/2001/XMLSchema#string

P932

2962424

http://www.w3.org/2001/XMLSchema#string